Molecular and Experimental Therapeutic Research in Oncology (METRO) Program

Program Leaders

Program Overview

The mission of the Molecular Oncology and Experimental Therapeutic Research Program is to bring together investigators to:

  • Identify and validate pathways critical to the initiation, progression, maintenance and metastasis of cancer;
  • Reduce the cancer burden through preclinical and early clinical drug development;
  • Determine optimal treatment approaches, combinations and sequences; and
  • Identify prognostic, predictive and surrogate markers of efficacy and resistance for active agents.

METRO program members focus on three specific aims:

Aim 1
Identifying pathways and molecular targets in cancer.

Aim 2
Understanding and exploiting the crosstalk between cancer cells, the tumor microenvironment and the immune system.

Aim 3
Evaluating cancer genomics and epigenetics.

A primary goal of the METRO Program is to match clinical research with lab research to facilitate a translational pipeline that brings a better understanding of cancer biology and new cancer therapies from bench to bedside.


Join the Program

Several tenure track positions with Georgetown Lombardi are available. See details here.


Watch a movie highlighting Georgetown Lombardi’s zebrafish work:

Zebrafish: Practically People, ​Transforming How We Study Disease is a 10-minute science documentary in which a close-knit group of scientists explain how the simple zebrafish is a largely untapped treasure trove for understanding, treating and curing human diseases.


Full Members

Associate Members